search
Back to results

Cryoballoon and Associated Esophageal Effects

Primary Purpose

Atrial Fibrillation

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Ablation with cryoenergy
Sponsored by
Baylor Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Atrial Fibrillation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Recurrent, symptomatic, drug-refractory, paroxysmal atrial fibrillation with planned cryoballoon pulmonary vein isolation
  2. Age >18 years
  3. Planned AF cryoablation procedure

Exclusion Criteria:

  1. LA diameter >55mm
  2. Severe LVH (LV wall ≥ 15mm)
  3. LA thrombus
  4. Decompensated heart failure
  5. Plans for left atrial ablation lesions beyond isolation of the pulmonary veins
  6. History of previous pulmonary vein isolation
  7. Inability to place esophageal temperature probe or TEE probe
  8. Previously documented phrenic nerve injury
  9. Known esophageal pathology (complete GI history worksheet)

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Other

    Arm Label

    Esophageal Effects

    Arm Description

    To determine the correlation between rate of temperature decline and nadir cryoballoon temperatures rate of temperature decline and nadir esophageal temperatures during pulmonary vein isolation. Esophageal temperature probe is used during cryoablation to measure temperatures and then a 4-7 days post procedure esophagoscopy is performed to evaluate the physical effects on the esophagus.

    Outcomes

    Primary Outcome Measures

    Rate of temperature decline
    Compare the correlation between rate of temperature decline and nadir cryoballoon temperatures rate of temperature decline and nadir esophageal temperatures during pulmonary vein isolation using a esotest probe esophageal temperature probe to record the esophageal temperatures
    Associate the development of symptoms
    To associate the development of symptoms (including dysphagia, chest pain, fever, "heartburn," or odynophagia) with the presence of ulcerations using a symptom questionnaire and visualize the esophagus 4-7 days post procedure via esophagoscopy

    Secondary Outcome Measures

    Phrenic nerve injury
    To collect data phrenic nerve injury assessed with patient symptom questionnaire
    Post procedure symptoms
    To collect data regarding post-procedure symptoms including but not limited to cough, hemoptysis, and pericardial effusion using a symptom questionnaire

    Full Information

    First Posted
    March 25, 2016
    Last Updated
    May 20, 2019
    Sponsor
    Baylor Research Institute
    Collaborators
    Medtronic
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03960346
    Brief Title
    Cryoballoon and Associated Esophageal Effects
    Official Title
    Cryoballoon Pulmonary Vein Isolation and Associated Esophageal Effects (Medtronic EGD)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2018
    Overall Recruitment Status
    Completed
    Study Start Date
    November 25, 2015 (Actual)
    Primary Completion Date
    May 2, 2018 (Actual)
    Study Completion Date
    May 2, 2018 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Baylor Research Institute
    Collaborators
    Medtronic

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The primary objectives are to determine the correlation between rate of temperature decline and nadir cryoballoon temperatures rate of temperature decline and nadir esophageal temperatures during pulmonary vein isolation. To accurately measure the distance between the esophagus and the ostium of each pulmonary vein intra-operatively. To attempt to create recommendations for esophageal temperature-guided ablation in order to increase the safety profile of cryoballoon pulmonary vein isolation (PVI) by providing one center's experience. By trending cryoballoon ablation temperatures and subsequent esophageal temperatures, data trends may emerge and be predictive for esophageal ulceration formation. These trends may include: Distance between esophagus and pulmonary vein in patients who developed post-ablation esophageal ulcerations Intra-procedure esophageal temperatures in patients who developed post-ablation esophageal ulcerations Intra-procedure cryoballoon temperatures in patients who developed post-ablation esophageal ulcerations As well as to associate the development of symptoms (including dysphagia, chest pain, fever, "heartburn," or odynophagia) with the presence of ulcerations.
    Detailed Description
    When treating atrial fibrillation and targeting various areas in the left atrium, electrophysiologists have the choice to perform ablation with RF energy or cryoenergy. Esophageal ulceration and in more rare cases, esophageal fistulae, are known complications of this ablation procedure. Though rare (0.1-0.25% fistula rate and 15-20% esophageal ulceration rate according to the most recent Heart Rhythm Society EHRA ECA consensus statement)1, the investigators would very much like to understand how to completely prevent these occurrences. Cryoenergy has more recently been introduced as an energy source used in the PVI procedure; therefore, for this energy source, rates of esophageal ulceration are not yet well-defined. Nine esophageal fistulae have occurred in the first approximately 130,000 cryoballoon procedures.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Atrial Fibrillation

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    2 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Esophageal Effects
    Arm Type
    Other
    Arm Description
    To determine the correlation between rate of temperature decline and nadir cryoballoon temperatures rate of temperature decline and nadir esophageal temperatures during pulmonary vein isolation. Esophageal temperature probe is used during cryoablation to measure temperatures and then a 4-7 days post procedure esophagoscopy is performed to evaluate the physical effects on the esophagus.
    Intervention Type
    Procedure
    Intervention Name(s)
    Ablation with cryoenergy
    Other Intervention Name(s)
    esophageal temperature-guided ablation
    Intervention Description
    Esophageal temperature-guided ablation using cryoengery and an esophageal temperature probe.
    Primary Outcome Measure Information:
    Title
    Rate of temperature decline
    Description
    Compare the correlation between rate of temperature decline and nadir cryoballoon temperatures rate of temperature decline and nadir esophageal temperatures during pulmonary vein isolation using a esotest probe esophageal temperature probe to record the esophageal temperatures
    Time Frame
    Up to 3 years
    Title
    Associate the development of symptoms
    Description
    To associate the development of symptoms (including dysphagia, chest pain, fever, "heartburn," or odynophagia) with the presence of ulcerations using a symptom questionnaire and visualize the esophagus 4-7 days post procedure via esophagoscopy
    Time Frame
    Up to 3 years
    Secondary Outcome Measure Information:
    Title
    Phrenic nerve injury
    Description
    To collect data phrenic nerve injury assessed with patient symptom questionnaire
    Time Frame
    Up to 3 years
    Title
    Post procedure symptoms
    Description
    To collect data regarding post-procedure symptoms including but not limited to cough, hemoptysis, and pericardial effusion using a symptom questionnaire
    Time Frame
    Up to 3 years

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Recurrent, symptomatic, drug-refractory, paroxysmal atrial fibrillation with planned cryoballoon pulmonary vein isolation Age >18 years Planned AF cryoablation procedure Exclusion Criteria: LA diameter >55mm Severe LVH (LV wall ≥ 15mm) LA thrombus Decompensated heart failure Plans for left atrial ablation lesions beyond isolation of the pulmonary veins History of previous pulmonary vein isolation Inability to place esophageal temperature probe or TEE probe Previously documented phrenic nerve injury Known esophageal pathology (complete GI history worksheet)

    12. IPD Sharing Statement

    Learn more about this trial

    Cryoballoon and Associated Esophageal Effects

    We'll reach out to this number within 24 hrs